These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 31100317)
1. The interaction between PLEKHG2 and ABL1 suppresses cell growth via the NF-κB signaling pathway in HEK293 cells. Nishikawa M; Nakano S; Nakao H; Sato K; Sugiyama T; Akao Y; Nagaoka H; Yamakawa H; Nagase T; Ueda H Cell Signal; 2019 Sep; 61():93-107. PubMed ID: 31100317 [TBL] [Abstract][Full Text] [Related]
2. PLEKHG2/FLJ00018, a Rho family-specific guanine nucleotide exchange factor, is tyrosine phosphorylated via the EphB2/cSrc signaling pathway. Sato K; Suzuki T; Yamaguchi Y; Kitade Y; Nagase T; Ueda H Cell Signal; 2014 Apr; 26(4):691-6. PubMed ID: 24378532 [TBL] [Abstract][Full Text] [Related]
3. Heterotrimeric G protein Gαs subunit attenuates PLEKHG2, a Rho family-specific guanine nucleotide exchange factor, by direct interaction. Sugiyama K; Tago K; Matsushita S; Nishikawa M; Sato K; Muto Y; Nagase T; Ueda H Cell Signal; 2017 Apr; 32():115-123. PubMed ID: 28108261 [TBL] [Abstract][Full Text] [Related]
4. Four-and-a-half LIM Domains 1 (FHL1) Protein Interacts with the Rho Guanine Nucleotide Exchange Factor PLEKHG2/FLJ00018 and Regulates Cell Morphogenesis. Sato K; Kimura M; Sugiyama K; Nishikawa M; Okano Y; Nagaoka H; Nagase T; Kitade Y; Ueda H J Biol Chem; 2016 Nov; 291(48):25227-25238. PubMed ID: 27765816 [TBL] [Abstract][Full Text] [Related]
5. Specific activation of PLEKHG2-induced serum response element-dependent gene transcription by four-and-a-half LIM domains (FHL) 1, but not FHL2 or FHL3. Nishikawa M; Sato K; Nakano S; Yamakawa H; Nagase T; Ueda H Small GTPases; 2019 Sep; 10(5):361-366. PubMed ID: 28489964 [TBL] [Abstract][Full Text] [Related]
6. p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr. Korus M; Mahon GM; Cheng L; Whitehead IP Oncogene; 2002 Jul; 21(30):4601-12. PubMed ID: 12096337 [TBL] [Abstract][Full Text] [Related]
7. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein. Brown S; Hutchinson CV; Aspinall-O'Dea M; Whetton AD; Johnson SM; Rees-Unwin K; Burthem J Eur J Haematol; 2014 Aug; 93(2):96-102. PubMed ID: 24617663 [TBL] [Abstract][Full Text] [Related]
8. Identification of a Rho family specific guanine nucleotide exchange factor, FLJ00018, as a novel actin-binding protein. Sato K; Handa H; Kimura M; Okano Y; Nagaoka H; Nagase T; Sugiyama T; Kitade Y; Ueda H Cell Signal; 2013 Jan; 25(1):41-9. PubMed ID: 23000341 [TBL] [Abstract][Full Text] [Related]
9. Microcephaly-dystonia due to mutated PLEKHG2 with impaired actin polymerization. Edvardson S; Wang H; Dor T; Atawneh O; Yaacov B; Gartner J; Cinnamon Y; Chen S; Elpeleg O Neurogenetics; 2016 Jan; 17(1):25-30. PubMed ID: 26573021 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl. Kawai H; Nie L; Yuan ZM Mol Cell Biol; 2002 Sep; 22(17):6079-88. PubMed ID: 12167702 [TBL] [Abstract][Full Text] [Related]
11. Threonine 680 phosphorylation of FLJ00018/PLEKHG2, a Rho family-specific guanine nucleotide exchange factor, by epidermal growth factor receptor signaling regulates cell morphology of Neuro-2a cells. Sato K; Sugiyama T; Nagase T; Kitade Y; Ueda H J Biol Chem; 2014 Apr; 289(14):10045-56. PubMed ID: 24554703 [TBL] [Abstract][Full Text] [Related]
12. FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway. Liu X; Mai H; Jiang H; Xing Z; Peng D; Kong Y; Zhu C; Chen Y BMC Cancer; 2019 Jul; 19(1):679. PubMed ID: 31291942 [TBL] [Abstract][Full Text] [Related]
13. Abl-1-bridged tyrosine phosphorylation of VASP by Abelson kinase impairs association of VASP to focal adhesions and regulates leukaemic cell adhesion. Maruoka M; Sato M; Yuan Y; Ichiba M; Fujii R; Ogawa T; Ishida-Kitagawa N; Takeya T; Watanabe N Biochem J; 2012 Feb; 441(3):889-99. PubMed ID: 22014333 [TBL] [Abstract][Full Text] [Related]
14. Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation. Pemovska T; Johnson E; Kontro M; Repasky GA; Chen J; Wells P; Cronin CN; McTigue M; Kallioniemi O; Porkka K; Murray BW; Wennerberg K Nature; 2015 Mar; 519(7541):102-5. PubMed ID: 25686603 [TBL] [Abstract][Full Text] [Related]
17. The tyrosine phosphatase TC48 interacts with and inactivates the oncogenic fusion protein BCR-Abl but not cellular Abl. Mitra A; Sasikumar K; Parthasaradhi BV; Radha V Biochim Biophys Acta; 2013 Jan; 1832(1):275-84. PubMed ID: 23124138 [TBL] [Abstract][Full Text] [Related]
18. The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias. Carrà G; Torti D; Crivellaro S; Panuzzo C; Taulli R; Cilloni D; Guerrasio A; Saglio G; Morotti A Oncotarget; 2016 Oct; 7(40):66287-66298. PubMed ID: 27563822 [TBL] [Abstract][Full Text] [Related]
19. SHP2 is required for BCR-ABL1-induced hematologic neoplasia. Gu S; Sayad A; Chan G; Yang W; Lu Z; Virtanen C; Van Etten RA; Neel BG Leukemia; 2018 Jan; 32(1):203-213. PubMed ID: 28804122 [TBL] [Abstract][Full Text] [Related]